Risks from a resurgence in Covid-19 cases and a possible tightening of measures both locally and abroad has not derailed RHB Group Research’s optimism on Singapore’s equity market.

“For 4Q2021, market outlook will continue to depend on how well stocks and sectors can con- tend with the current Covid-19 constrained growth [and] elevated inflation amidst supply chain disruptions, expectations of an early interest rate hike and corporate efforts to maximise operational efficiencies,” the brokerage’s research head, Shekhar Jaiswal, explains in an Oct 20 report.

From his perspective, there are a number of Singapore stocks that continue to offer opportunities to accumulate stocks that leverage on an economic re-opening. Counters that offer better earnings visibility either from business restructuring or structural and inorganic growth, look promising too, reckons Jaiswal. Jaiswal has taken a liking to banks as well as the consumer, healthcare, industrial, telecom and transport sectors, based on “expectations of a better 2022”, as he holds the view that Singapore’s economic reopening as an eventuality will sustain them over the next 12 months.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook